S1028 Symptoms and Laboratory Values as Proxies for Endoscopic and Histologic Clinical Endpoints in Ulcerative Colitis: A Mediation Analysis Based on Upadacitinib Phase 3 Induction Trials
Abstract
Marla Dubinsky, MD1, Min Yang, MD, PhD, MS2, Mirko Fillbrunn, PhD2, Silvio Danese, MD, PhD3, Johan Burisch, MD, PhD4, Satoshi Tanida, MD5, Dolly Sharma, PhD6, Dapo Ilo, MBBS, MRCS, MSc6, Wen Zhou, MD, PhD6, Yuri Sanchez-Gonzalez, PhD6, Laurent Peyrin-Biroulet, MD7. Icahn School of Medicine, Mount Sinai, NY; Analysis Group, Inc., Boston, MA; IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Molise, Italy; Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Hovedstaden, Denmark; Education and Research Center for Community Medicine, Nagoya City University, and Gamagori City Hospital, Gamagori, Aichi, Japan; AbbVie, Inc., North Chicago, IL; University Hospital of Nancy, Lorraine University, Vandoeuvre, Franche-Comte, France.
Read the paper
Related studies
- Meta-analysis and the science of research synthesis
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- Cluster Randomized Controlled Trial
- Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
- Disease Free Survival and Local Recurrence for Laparoscopic Resection Compared to Open Resection of Stage II-III Rectal Cancer: Follow up Results of the ACOSOG Z6051 Randomized Controlled Trial
- The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.